Conference Grant (R13) for 16th Symposium on Cochlear Implants in Children to be held July10-13, 2019 in Hollywood (FL) on clinical research of interest to cochlear implant clinicians and scientists

项目摘要/摘要 本申请寻求为第十六届儿童人工耳蜗术研讨会(CI2019)提供部分资金 儿科)由美国人工耳蜗术联盟与加州大学合作组织 迈阿密米勒医学院将于2019年7月10日至13日在好莱坞(FL)举行。CI临床研究会议 为整个CI护理连续体的临床医生(即耳鼻喉科医生、听力专家、语音医生)提供独特的机会 病理学家、聋人教育家、心理学家、社会工作者)和科学家在这样一个环境中共同学习 在更广泛的内容上不同于针对特定临床医生的会议，例如耳鼻喉科医生或听力学专家。在……里面 2019年，关注的焦点是如何才能最好地“治疗整个孩子”--而不仅仅是听力损失。 到目前为止，CI儿科临床研究会议主要集中在技术和 为“传统”儿科人群提供最佳结果的治疗模式 导致大多数早期接受CI的儿童发展出与通常听力正常的同龄人平行的语言。 随着临床模型的发展，我们从为说英语的儿童提供深刻的双边 听力损失和无继发性残疾的不同CI人群，非常小和更大的儿童， (两侧)较轻和不同程度的听力损失、多发性残疾和那些家庭居住在 我们但不会说英语。有必要了解如何从这一点上适当地对待儿童 更复杂和多样化的人口，包括那些语言发展结果不同的人。 学生可以申请免除注册和经济资助，并可以进入学生海报 与一个跨学科委员会进行的面试竞争。会后研讨会在北京举行 西班牙语将把美国和拉丁美洲的与会者聚集在一起。场馆位于大西洋上， 室内和室外都有灵活的空间，以鼓励讨论、联网和解决问题 在有经验的和新兴的临床医生/科学家和学生之间以及在他们之间的预定会议之后。 这项建议的具体目的是：(1)提供一个讨论研究实践原则的论坛 由多学科团队为解决家庭变量、社会和情感发展、存在 可能受益于人工耳蜗的儿童的其他残疾、双语能力和不同程度的听力损失 植入，但其需求和结果可能与“传统”候选人不同；(2)确保 会议地点和形式结合了演示文稿类型、讨论工具和非正式 与处于职业生涯不同阶段的一系列临床医生和科学家建立联系-高度 专业临床医生/科学家、正在开展工作的个人以及受益的学生和研究员 与更有经验的同事互动；以及(3)检查CI候选人的可变性 旨在改善那些得不到预期结果的儿童的结果 通过临床和基础研究解决这种变异性。

Project Summary/Abstract This application seeks partial funding for the 16th Symposium on Cochlear Implants in Children (CI2019 Pediatric) being organized by the American Cochlear Implant Alliance collaboratively with the University of Miami Miller School of Medicine on July 10-13, 2019 in Hollywood (FL). The CI clinical research meetings offer a unique opportunity for clinicians from across the CI care continuum (i.e., ENTs, audiologists, speech pathologists, deaf educators, psychologists, social workers) and scientists to learn together in a setting that differs from conferences for specific clinicians such as ENTs or audiologists on more generalized content. In 2019, the focus is how best to “treat the whole child”—beyond hearing loss. To date, CI pediatric clinical research conferences have focused primarily on the technology and therapeutic models that produce the best outcomes for the “traditional” pediatric population, a model that has led to most children who received early CI developing language that paralleled typically hearing peers. As clinical models evolved, we moved from serving English-speaking children with profound bilateral hearing loss and no secondary disabilities to a diverse CI population of very young and older children with lesser and varying (on each side) hearing loss, multiple disabilities, and those whose families reside in the US but do not speak English. There is a need to understand how to appropriately treat children from this more complex and diverse population, including those with variable language development outcomes. Students may apply for waived registration and financial support, and may enter a student poster competition with interviews conducted by an interdisciplinary committee. A post-conference seminar in Spanish will bring together US and Latin American attendees. The venue, located on the Atlantic Ocean, has flexible spaces indoors and out to encourage discussion, networking and problem-solving before and after scheduled sessions among and between experienced and emerging clinician/scientists and students. The specific aims of this proposal are to: (1) Offer a forum for discussion of research to practice principles by multidisciplinary teams for addressing family variables, social and emotional development, presence of other disabilities, bilingualism, and varying levels of hearing loss in children who may benefit from cochlear implantation but whose needs and outcomes may differ from the “traditional” candidate; (2) Ensure that the meeting venue and format utilizes a combination of presentation types, discussion tools and informal networking to engage a range of clinicians and scientists who are at different stages in their careers—highly expert clinicians/scientists, those individuals whose work is emerging, and students and fellows who benefit from interacting with more experienced colleagues; and (3) Examine the variability in the CI candidate population with the aim of improving results for those children who do not derive the expected outcome with CI via clinical and basic research that can address such variability.